Clarivate Plc — Company profile
Technology · Information Technology Services · United Kingdom
Last price 1.65 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.06B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Details
| Name | Clarivate Plc |
| Sector | Technology |
| Industry | Information Technology Services |
| Employees | 12000 |
| Founded | 2016 |
| Ceo | Matitiahu Shem Tov |
| Country | United Kingdom |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | JE00BJJN4441 |
| Cusip | G21810109 |
| Cik | 1764046 |
| Sic | 7374 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Matitiahu Shem Tov | Chief Executive Officer and Director |
| Bar Veinstein | President of Academia and Government |
| Michael Easton | Executive Vice President and Chief Financial Officer |
| Matthew Lisowski | Senior Vice President and Chief Accounting Officer |
| William E. Graff | Executive Vice President and Chief Information Officer |
| Mark J. Donohue C.P.A. | Head of Investor Relations |
| John Doulamis | Senior Vice President and General Counsel |
| Gwenan White | Senior Vice President of Communications and Brand |
| Darien Krimmert | Senior Vice President and Head of People |
| Richard C. Finch | Senior Vice President of Life Sciences and Healthcare |
Contact
| Address | 70 St. Mary Axe, London, EC3A 8BE, United Kingdom |
| Phone | 44 20 7433 4000 |
| Website | https://www.clarivate.com |